HCM
NVO

Highbridge Capital Management’s Novo Nordisk NVO Stock Holding History

Highbridge Capital Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-125,000
Closed -$3.08M – 1202
2018
Q1 		$3.08M Buy
+125,000
New +$3.28M 0.05% 376

Other funds holding NVO

Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
SGA
Sustainable Growth Advisers Stamford, Connecticut $10.6B AUM 2.6% 1-Year Est. Return

Highbridge Capital Management's NVO Position: Q2 2018 in Review

Highbridge Capital Management sold out of Novo Nordisk (NVO) in Q2 2018, closing a stake of 125,000 shares — an estimated $3.08M sold.

Highbridge Capital Management first reported a position in NVO in Q1 2018 and held it in 1 quarter. The position peaked at $3.08M in Q1 2018. 537 funds tracked by Wall St. Rank hold NVO as of Q2 2018.

  • Highbridge Capital Management reported no remaining Novo Nordisk position as of Q2 2018 after selling out during the quarter.
  • Highbridge Capital Management sold 125,000 Novo Nordisk shares in Q2 2018, an estimated $3.08M.
  • Highbridge Capital Management first reported a position in Novo Nordisk in Q1 2018 and held it in 1 quarter.
  • Highbridge Capital Management's Novo Nordisk position peaked at $3.08M in Q1 2018.
  • 537 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2018.

Based on Highbridge Capital Management's 13F filing for Q2 2018, filed 14 Aug 2018.